The top 100 stock
market authors
selected for publication
market authors
selected for publication
D. Linsenbardt
»
Comments
» Single Comment
| 
Comments by Ticker
1 comment
Rating: 0
(0 
-
0 
)
-
0 )
-
The Seeking Alpha 100
See all
Seeking Alpha 100 » -
Fastest Climbers
Authors with the largestSee all
increase in followers
in the last 7 days
Fastest Climbers » -
Top Commenters
Top commenters,See all
as ranked by their peers
Top Commenters » -
Top Instabloggers
The 100 most activeSee all
Instabloggers.
Top Instabloggers » -
Top StockTalkers
TopSee all
StockTalkers.
Top StockTalkers »
-
Today Pfizer announced that they pulled out of phase III clinical trials for their CB1 antagonist due to "a changing regulatory environment"...
Nov 05 17:29 pm
|Rating:
0
0
All Comments by D. Linsenbardt »Merck Buries Taranabant: Farewell Cannabinoid Antagonist Field [View article]
I wonder if there is public access various aspects of the pharmacology of these compounds... (i.e. comparisons to Rimonabant)